Effects of clopidogrel on the pharmacokinetics and pharmacodynamics of ciprofol in rats

LU Ming; YIN Xiaoyu; LI Wenli; LI Shan; LI Xiangchen; ZHANG Zhiqing

doi:10.6039/j.issn.1001-0408.2025.02.08

您当前的位置：

首页 >

文章列表页 >

Effects of clopidogrel on the pharmacokinetics and pharmacodynamics of ciprofol in rats

更新时间：2025-09-25

- Effects of clopidogrel on the pharmacokinetics and pharmacodynamics of ciprofol in rats
- ZHONGGUO YAOFANG Vol. 36, Issue 2, Pages: 179-184(2025)
- 作者机构：
  
  1.河北医科大学第二医院药学部，石家庄　050052
  2.河北省人民医院药学部，石家庄　050051
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2025.02.08
  CLC： R969.2
- Received：30 July 2024，
  
  Revised：2024-12-23，
  
  Accepted：24 December 2024，
  
  Published：30 January 2025
- 稿件说明：
移动端阅览
路明,尹晓玉,李文利,等.氯吡格雷对大鼠体内环泊酚药动学和药效学的影响[J].中国药房,2025,36(02):179-184.

LU Ming,YIN Xiaoyu,LI Wenli,et al.Effects of clopidogrel on the pharmacokinetics and pharmacodynamics of ciprofol in rats[J].ZHONGGUO YAOFANG,2025,36(02):179-184.
路明,尹晓玉,李文利,等.氯吡格雷对大鼠体内环泊酚药动学和药效学的影响[J].中国药房,2025,36(02):179-184. DOI： 10.6039/j.issn.1001-0408.2025.02.08.

LU Ming,YIN Xiaoyu,LI Wenli,et al.Effects of clopidogrel on the pharmacokinetics and pharmacodynamics of ciprofol in rats[J].ZHONGGUO YAOFANG,2025,36(02):179-184. DOI： 10.6039/j.issn.1001-0408.2025.02.08.

摘要

目的

考察氯吡格雷对大鼠体内环泊酚药动学和药效学的影响。

方法

18只雄性SD大鼠随机分为对照组、氯吡格雷正常剂量组和氯吡格雷高剂量组，每组6只。氯吡格雷正常剂量组和氯吡格雷高剂量组大鼠分别灌胃7.5、15 mg/kg的氯吡格雷，对照组大鼠灌胃同体积的0.5%羧甲基纤维素钠溶液，每天1次，连续给药14 d后于大鼠尾静脉注射环泊酚2.4 mg/kg。在结束注射后2、4、8、12、16、20、30、45、60 min时于眼内眦取血，统计各组大鼠的翻正反射消失（LORR）持续时间。大鼠血浆经乙腈沉淀蛋白后，以氘代环泊酚为内标，以Symmetry C

为色谱柱，以乙腈-含5 mmol/L乙酸铵的0.01%氨水溶液（梯度洗脱）为流动相，采用液相色谱-串联质谱法检测血浆中环泊酚的质量浓度，采用DAS 2.0软件计算各组大鼠的药动学参数。

结果

与对照组比较，氯吡格雷正常剂量组和氯吡格雷高剂量组大鼠体内环泊酚的药时曲线下面积和平均驻留时间均显著增加或延长，血浆清除率均显著降低，LORR持续时间分别延长了19.5%和23.9%，差异均有统计学意义（

＜0.05）。氯吡格雷两个剂量组大鼠体内环泊酚药动学参数和LORR持续时间比较差异均无统计学意义（

＞0.05）。

结论

氯吡格雷可抑制环泊酚的体内代谢，并延长大鼠的LORR持续时间。

Abstract

OBJECTIVE

To investigate the effects of clopidogrel on the pharmacokinetics and pharmacodynamics of ciprofol in rats.

METHODS

Eighteen male SD rats were randomly divided into control group， clopidogrel normal-dose group and clopidogrel high-dose group， with 6 rats in each group. Among them， rats in the normal-dose group and high-dose group were given 7.5 mg/kg and 15 mg/kg clopidogrel by gavage， respectively， and rats in the control group were given the same volume of 0.5% sodium carboxymethyl cellulose solution， once a day， for 14 consecutive days. Afterward， 2.4 mg/kg ciprofol was injected by tailvein and blood samples were collected from the inner canthus of the eye at 2， 4， 8， 12， 16， 20， 30， 45 and 60 min after the end of the administration. During this period， the duration of the loss of righting reflex （LORR） in rats was counted. After the proteins were precipitated by acetonitrile， the rat plasma sample was analyzed by LC-MS/MS using deuterated ciprofol as the internal standard， Symmetry C

as the chromatographic column， and acetonitrile-0.01% ammonia solution containing 5 mmol/L ammonium acetate （gradient elution） as the mobile phase to detect the concentration of ciprofol in the plasma. The pharmacokinetic parameters in rats were calculated by using DAS 2.0 software.

RESULTS

Compared with control group， area under the drug concentration-time curve and mean residence time of ciprofol increased or prolonged significantly， while plasma clearance decreased significantly in clopidogrel normal-dose and high-dose groups； the duration of LORR in rats was prolong

ed by 19.5% and 23.9%， with statistical difference （

＜0.05）. However， there was no statistically significant difference in the pharmacokinetic parameters or LORR duration of ciprofol between the different dose groups of clopidogrel （

＞0.05）.

CONCLUSIONS

Clopidogrel could inhibit the metabolism of ciprofol in rats and prolong the duration of LORR.

关键词

Keywords

references

NYAMABO A K ， YU H ， LIU Z ， et al . Drug-drug interaction prediction with learnable size-adaptive molecular substructures [J ] . Brief Bioinform ， 2022 ， 23 （ 1 ）： bbab441 .

WU H ， XING Y ， GE W H ， et al . Drug-drug interaction extraction via hybrid neural networks on biomedical literature [J ] . J Biomed Inform ， 2020 ， 106 ： 103432 .

KALGUTKAR A S ， OBACH R S ， MAURER T S . Mecha-nism-based inactivation of cytochrome P450 enzymes：chemical mechanisms，structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions [J ] . Curr Drug Metab ， 2007 ， 8 （ 5 ）： 407 - 447 .

MIRZAEI M S ， IVANOV M V ， TAHERPOUR A A ， et al . Mechanism-based inactivation of cytochrome P450 enzymes：computational insights [J ] . Chem Res Toxicol ， 2021 ， 34 （ 4 ）： 959 - 987 .

RICHTER T ， MÜRDTER T E ， HEINKELE G ， et al . Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine [J ] . J Pharmacol Exp Ther ， 2004 ， 308 （ 1 ）： 189 - 197 .

LU M ， LIU J ， WU X K ， et al . Ciprofol：a novel alternative to propofol in clinical intravenous anesthesia [J ] . Biomed Res Int ， 2023 ， 2023 ： 7443226 .

LIAO J ， LI M T ， HUANG C L ， et al . Pharmacodynamics and pharmacokinetics of HSK3486，a novel 2，6-disubstituted phenol derivative as a general anesthetic [J ] . Front Pharmacol ， 2022 ， 13 ： 830791 .

中国心胸血管麻醉学会非心脏麻醉分会，中国医师协会心血管内科医师分会，中国心血管健康联盟 . 抗血栓药物围手术期管理多学科专家共识 [J ] . 中华医学杂志， 2020 ， 100 （ 39 ）： 3058 - 3074 .

The Non-Cardiac Anesthesia Branch of the Chinese Socie-ty of Cardiothoracic Anesthesia ， the Cardiovascular Physician Branch of Chinese Medical Doctor Association ， Chinese Cardiovascular Health Alliance . Multidisciplinary expert consensus on perioperative management of antithrombotic drugs [J ] . Natl Med J China ， 2020 ， 100 （ 39 ）： 3058 - 3074 .

JUPITER D C ， FANG X ， ADHIKARI D ， et al . Safety of continued clopidogrel use in the preoperative course of gastrointestinal surgery：a retrospective cohort study [J ] . Ann Surg ， 2017 ， 265 （ 2 ）： 370 - 378 .

ABDULHAMID A K ， KHALAF R J . Safety of not withholding clopidogrel therapy during the immediate several days pre- and post-trans-urethral resection of prostate（TURP）：a retrospective cohort study [J ] . Int Urol Nephrol ， 2022 ， 54 （ 5 ）： 985 - 992 .

MAXFIELD D G ， BERNASEK T L ， ENGEL C C ， et al . Is it safe to continue clopidogrel in elective hip and knee arthroplasty? [J ] . J Arthroplasty ， 2022 ， 37 （ 9 ）： 1726 - 1730 .

YANG D D ， HU Y ， RUAN Z R ， et al . Drug-drug interaction of ciprofol injectable emulsion with mefenamic acid capsules in healthy subjects [J ] . Br J Clin Pharmacol ， 2023 ， 89 （ 10 ）： 3165 - 3174 .

国家药典委员会 . 中华人民共和国药典：四部 [M ] . 2020年版 . 北京：中国医药科技出版社， 2020 ： 466 - 472 .

National Pharmacopoeia Commission . Pharmacopoeia of the People’s Republic of China：part Ⅳ [M ] . 2020 edition. Beijing ： China Medical Science and Technology Press ， 2020 ： 466 - 472 .

TAI S K ， MA J Y ， LEUNG L S . Medial septal cholinergic neurons modulate isoflurane anesthesia [J ] . Anesthesio-logy ， 2014 ， 120 （ 2 ）： 392 - 402 .

QIN L L ， REN L ， WAN S L ， et al . Design，synthesis，and evaluation of novel 2，6-disubstituted phenol derivatives as general anesthetics [J ] . J Med Chem ， 2017 ， 60 （ 9 ）： 3606 - 3617 .

LEE K M ， HAN S M ， LEE S ， et al . Fluoride-assisted li-quid chromatography-tandem mass spectrometry method for simultaneous analysis of propofol and its metabolites without derivatization in urine [J ] . J Chromatogr A ， 2021 ， 1652 ： 462360 .

LOH G O K ， WONG E Y L ， GOH C Z ， et al . Simulta-neous determination of tramadol and paracetamol in human plasma using LC-MS/MS and application in bioequivalence study of fixed-dose combination [J ] . Ann Med ， 2023 ， 55 （ 2 ）： 2270502 .

徐叔云 . 药理实验方法学 [M ] . 3版 . 北京：人民卫生出版社， 2002 ： 202 - 204 .

XU S Y . Pharmacological experimental methodology [M ] . 3rd edition . Beijing ： People’s Health Publishing House ， 2002 ： 202 - 204 .

黄继汉，黄晓晖，陈志扬，等 . 药理试验中动物间和动物与人体间的等效剂量换算 [J ] . 中国临床药理学与治疗学， 2004 ， 9 （ 9 ）： 1069 - 1072 .

HUANG J H ， HUANG X H ， CHEN Z Y ， et al . Dose conversion among different animals and healthy volunteers in pharmacological study [J ] . Chin J Clin Pharmacol Ther ， 2004 ， 9 （ 9 ）： 1069 - 1072 .

中华医学会心血管病学分会，中华心血管病杂志编辑委员会 . 抗血小板治疗中国专家共识 [J ] . 中华心血管病杂志， 2013 ， 41 （ 3 ）： 183 - 194 .

Cardiovascular Disease Branch of Chinese Medical Association ， Editorial Committee of Chinese Journal of Car-diovascular Disease . Expert consensus on antiplatelet therapy in China [J ] . Chin J Cardiol ， 2013 ， 41 （ 3 ）： 183 - 194 .

方素君，蔡金星，邹奇锋，等 . CYP2C19基因中间代谢型ACS患者双倍剂量氯吡格雷和标准剂量替格瑞洛疗效与安全性评价 [J ] . 中国医院药学杂志， 2021 ， 41 （ 14 ）： 1461 - 1465，1469 .

FANG S J ， CAI J X ， ZOU Q F ， et al . Efficacy and safety of double-dose clopidogrel versus standard-dose ticagrelor in acute coronary syndrome patients with CYP2C19 intermediate metabolized genotype [J ] . Chin J Hosp Pharm ， 2021 ， 41 （ 14 ）： 1461 - 1465，1469 .

GALLI M ， OCCHIPINTI G ， BENENATI S ， et al . Comparative effects of different antiplatelet strategies in car-riers of CYP2C19 loss-of-function alleles：a network meta-analysis [J ] . Eur Heart J Cardiovasc Pharmacother ， 2024 ， 10 （ 6 ）： 526 - 536 .

NISHIYA Y ， HAGIHARA K ， ITO T ， et al . Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine，clopidogrel，and the thiolactone metabolite of prasugrel [J ] . Drug Metab Dispos ， 2009 ， 37 （ 3 ）： 589 - 593 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Chinese expert consensus for therapeutic drug monitoring of meropenem

Study on the optimization of processing technology of honey bran-fried Atractylodis Rhizoma and its anti-gastric ulcer effect

Pharmacodynamic study of sinapine thiocyanate dissoluble microneedle for acupoint administration against bronchial asthma

抗真菌药的PK/PD研究和临床用药优化

盐酸莫西沙星氯化钠注射液治疗下呼吸道感染的药动学和药效学研究

Related Author

Society of Therapeutic Drug Monitoring Pharmacists of Chinese Pharmacists Association

Writing Group of the Chinese Expert Consensus for Therapeutic Drug Monitoring of Meropenem

LU Meixia

ZHU Wenting

HUANG Yaojie

LIU Zhiwei

DING Yan

SHI Linfeng

Related Institution

Dept. of Pharmacy， the Affiliated Hospital of Jiangxi University of Chinese Medicine

School of Pharmacy， Jiangxi University of Chinese Medicine

School of Pharmacy， Guizhou University of Traditional Chinese Medicine/National Engineering Technology Research Center for Miao Medicine/Guizhou Engineering Technology Research Center for Traditional Chinese Medicine Processing and Preparation

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰